RocRock Biotechnology
PrivateLast Round
Series A
Nov 20, 2025
Total Funding Raised
$6.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RocRock Biotechnology is a biotechnology company that develops engineered macrophage technology and macrophage-based drug therapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RocRock Biotechnology Comparables
Compare RocRock Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellOrigin Biotech | 88% | |
| Carisma Therapeutics | 81% | |
| Thunder Biotech | 81% |
RocRock Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 20, 2025 | ||||
| Angel | Oct 1, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2025
$7M round completed.
- Oct 1, 2022
Completed an angel funding round.
RocRock Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RocRock Biotechnology's valuation, stock price, and market status.
Is RocRock Biotechnology a public or private company?
RocRock Biotechnology is a private company.
What is the current stock price of RocRock Biotechnology?
RocRock Biotechnology is a private company with no public stock price. Caplight tracks RocRock Biotechnology's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is RocRock Biotechnology worth (valuation)?
Valuation information for RocRock Biotechnology is not publicly available.
Can I buy RocRock Biotechnology stock?
RocRock Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RocRock Biotechnology's last funding round?
RocRock Biotechnology's most recent funding round was Series A on November 20, 2025.
Who are the main investors in RocRock Biotechnology?
Investor information for RocRock Biotechnology is not publicly disclosed.
Will RocRock Biotechnology IPO soon?
No public IPO plans have been announced for RocRock Biotechnology.
How can I track RocRock Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RocRock Biotechnology's secondary market activity and sign up for updates.